BIODELIVERY SCIENCES INTERNATIONAL, INC.

"(BUPRENORPHINE) BUCCAL FILM" AND "75 · 150 · 300 · 450 · 600 · 750 · 900 MCG"

Class 005: [ Pharmaceutical preparations for the treatment and prevention of pain ]; Class 042: Research and development and consultation related thereto in the field of pharmaceutical preparations and substances; Class 044: Providing health information

pharmaceutical preparations, namely, analgesics

Pharmaceutical research and development

Class 005: pharmaceutical preparations for the relief of pain

Class 005: pharmaceutical preparations for the relief of pain

Class 005: pharmaceutical preparations for the relief of pain

Class 005: pharmaceutical preparations for the relief of pain

Class 005: pharmaceutical preparations for the relief of pain

Class 005: pharmaceutical preparations for the relief of pain

pharmaceuticals, namely, formulations of lysosomal enzymes for replacement of missing lysosomai enzymes due to genetic defects such as glucocerebrosidase deficiency, delivered orally or by intervenous administration, and for human and veterinary usage

pharmaceuticals, topical nutraceuticals, and topical cosmetics, namely, anti-acne medication, anti-balding medication such as dihydrotestosterone inhibitors, and systemic delivery by means of transdermal absorption of protein, nucleoside, and steroid therapeutics such as Human Growth Hormone, Testosterone, Estrogen, and anti-virals, and for delivery of antiinflammatories such as ibuprofen, aspirin, acetaminophen, silibin, quercetin, alpha-lipoic acid, collagen, Vitamin D, Vitamin C, antioxidants such as superoxide dismutase and glutathione, melanin, tanning agents such as melanin, skin conditioning agents such as moisturizers, and skin peeling agents such as glycolic acid

DRUG DELIVERY APPARATUS PROVIDING BOTH ORAL AND SYSTEMIC DELIVERY OF VARIOUS PHARMACEUTICALS, NUTRACEUTICALS, OVER-THE-COUNTER DRUGS, NUTRITION, VACCINES, GENE THERAPIES, MEDICAL TREATMENT, AND FOR TREATMENT OF SPECIFIC TYPES OF INFECTIOUS DISEASES, NAMELY, INCLUDING HEPATOBILIARY DISEASES, MUSCULAR DISEASES, NEURAL DISEASES, CARDIOVASCULAR DISEASES, ENDOCRINE DISEASES, ARTHRITIC DISEASES, HEMATOLOGIC DISEASES, OPHTHALMIC DISEASES, OLFACTORY DISEASES, GASTROINTESTINAL DISEASES, REPRODUCTIVE ORGAN DISEASES, URINOGENITAL DISEASES, CUTANEOUS DISEASES, AUTO-IMMUNE DISEASES, SKELETAL AND BONEY DISEASES, LYMPHATIC DISEASES, MUCOUS MEMBRANE, CONNECTIVE TISSUE DISEASES, OTOLARYNGOTIC DISEASES, PREGNANCY AND PRENATAL DISEASES

Human and veterinary pharmaceutical preparations for treatment of livestock and domestic animals, using novel therapeutics and novel drug delivery mechanisms to treat and prevent cancer in a way that reduces unwanted side effects and increases the effectiveness of the therapeutics

Drugs for treatment of medical and veterinary diseases by delivering the medicine to the specific sites within the body to achieve prescribed treatment, namely, nanocochleates of phosphadidyserine and calcium as the delivery vehicle of transferring drugs to the site of treatment, Amphotericin for the treatment of fungal infection, Tobramycin and Gelanamyycin delivered to body treatment sites by nanocochleates

Mark is used upon medical products, namely, pharmaceutical preparations and nutriceuticals for use for the treatment of diseases of the body; "generics"

Nutriceutical preparations for use for the treatment of human diseases in the category of hepatobiliary diseases, muscular diseases, neural diseases, cardiovascular diseases, endocrine diseases, arthritic, hematological diseases, ophthalmic diseases, olfactory diseases, gastrointestinal diseases, reproductive organ diseases, renal diseases, pulmonary diseases, pancreatic diseases, urinogential diseases, cutaneous diseases, auto-immune diseases, skeletal and bony diseases, lymphatic diseases, mucous membrane diseases, connective tissue diseases, otolaryngotic diseases, pregnancy and prenatal diseases; "NUTRICEUTICALS"

Used for pharmaceuticals, namely, formulations of lysosomal enzymes for replacement of missing lysosomal enzymes due to genetic defects such as glucocerebrosidase deficiency, delivered orally or by intervenous administration, and for human and veterinary usage

A cochleate delivery vehicle not containing pharmaceuticals used to provide both oral and systemic delivery of others' pharmaceuticals, nutriceuticals, nutrition, vaccines and gene therapies to the patient; "IV"

pharmaceutical preparations and nutriceuticals for treatment of diseases of the nose

PHARMACEUTICALS AND NUTRACEUTICALS FOR USE IN THE TREATMENT OF HEPATOBILIARY DISEASES, MUSCULAR DISEASES, NEURAL DISEASES, CARDIOVASCULAR DISEASES, ENDOCRINE DISEASES, ARTHRITIC DISEASES, HEMATOLOGICAL DISEASES, OPHTHALMIC DISEASES, OLFACTORY DISEASES, GASTROINTESTINAL DISEASES, REPRODUCTIVE ORGAN DISEASES, URINOGENITAL DISEASES, CUTANEOUS DISEASES, AUTO-IMMUNE DISEASES, SKELETAL AND BONEY DISEASES, LYMPHATIC DISEASES, MUCOUS DISEASES, CONNECTIVE TISSUE DISEASES, OTOLARYNGOTIC DISEASES, PREGNANCY AND PRENATAL DISEASES; "PHARMACEUTICALS"

Medical products, namely pharmaceutical preparations and nutriceuticals for use in human and veterinary medicine for the prevention and treatment of diseases, using cell targeted delivery technology to deliver therapeutics to specific cell types in infectious diseases, for the treatment of hepatobiliary diseases, muscular diseases, neural diseases, cardiovascular diseases, endocrine diseases, arthritic diseases, hematologic diseases, ophthalmic diseases, olfactory diseases, gastrointestinal diseases, reproductive organ diseases, renal diseases, pulmonary diseases, pancreatic diseases, urinogential diseases, cutaneous diseases, auto-immune diseases, skeletal and boney diseases, lymphatic diseases, mucous membrane diseases, connective tissue diseases, tissue diseases, otolaryngotic diseases, pregnancy and prenatal diseases; "RX"